WallStSmart
IPSC

Century Therapeutics Inc

NASDAQ: IPSC · HEALTHCARE · BIOTECHNOLOGY

$2.20
+0.00% today

Updated 2026-04-29

Market cap
$396.78M
P/E ratio
P/S ratio
3.64x
EPS (TTM)
$-0.14
Dividend yield
52W range
$0 – $3
Volume
1.3M

Century Therapeutics Inc (IPSC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201520162019202020212022202320242025
Revenue$950.79M$470.32M$0.00$0.00$1.06M$5.20M$2.23M$6.59M$109.16M
Revenue growth (YoY)-50.5%-100.0%+391.4%-57.0%+194.8%+1556.8%
Cost of revenue$888.81M$467.84M$249000.00$1.75M$4.58M$10.07M$13.04M$13.30M$13.10M
Gross profit$61.97M$2.48M$-249000.00$-1.75M$-4.58M$5.20M$2.23M$6.59M$96.06M
Gross margin6.5%0.5%-433.1%100.0%100.0%100.0%88.0%
R&D$11.44M$9.09M$14.27M$39.68M$75.65M$97.17M$92.71M$107.24M$95.67M
SG&A$108.81M$81.39M$5.77M$9.49M$19.23M$31.86M$34.71M$33.16M$24.00M
Operating income$-20.03M$-49.18M$-94.88M$-133.83M$-146.55M$-138.14M$-15.04M
Operating margin0.0%0.0%-8968.1%-2574.2%-6556.9%-2096.5%-13.8%
EBITDA$-244.52M$-51.44M$-89.92M$-121.20M$-121.21M$-111.47M$-1.94M
EBITDA margin0.0%0.0%-8499.4%-2331.2%-5423.2%-1691.8%-1.8%
EBIT$-244.77M$-53.19M$-94.51M$-129.64M$-134.25M$-124.78M$-15.04M
Interest expense$0.00$0.00$0.00$381000.00$1.27M$1.10M$540000.00$0.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-244.77M$-53.58M$-95.82M$-130.93M$-136.67M$-126.57M$-9.58M
Net income growth (YoY)+78.1%-78.9%-36.6%-4.4%+7.4%+92.4%
Profit margin0.0%0.0%-9057.1%-2518.4%-6115.1%-1920.9%-8.8%